![Page 1: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/1.jpg)
Insights from experimentally infecting humans with hookworm
Emeritus Professor Rick SpeareSchool of Public Health, Tropical Medicine and Rehabilitation Sciences, James Cook University
&Director, Tropical Health Solutions Townsville, Queensland, Australia
17 October 2012
Presentation to Medical Research Council (Gambia)Available at: http
//www.tropicalhealthsolutions.com/hookworm
![Page 2: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/2.jpg)
Orientation - map
Townsville
Anton Breinl Centre for Public Health and Tropical
Medicine
![Page 3: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/3.jpg)
Dr John Croese & Castle Hill
![Page 4: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/4.jpg)
Hygiene Hypothesis: STH style
• Although soil transmitted helminths (STH) cause significant morbidity in developing countries, the lack of STH in developed countries is hypothesised to increase the incidence of allergic and autoimmune disease.
• STH will induce a Th2 response against the parasite and this will be down-regulated by regulatory T cells which will also non-specifically down-regulate the destructive immune response (Th1) of the host that is responsible for allergic and autoimmune diseases.
![Page 5: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/5.jpg)
Relationship between prevalence of multiple sclerosis and STH
Fleming & Cook. Neurology 2006;67:2085
• Trichuris trichiura as a marker of STH & low levels of community sanitation
• Prevalence of MS & Tt in 35 countries
• Correlational study
![Page 6: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/6.jpg)
Multiple Sclerosis vs Whipworm
• Prevalence of MS falls steeply once threshold of 10% Tt is reached
• This applied for marginalised populations sharing same country (Jews – Arabs in Israel)
Fleming & Cook. Neurology 2006;67:2085
10%Is the protective effect
due to Tt or gut exposure to
pathogens?
![Page 7: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/7.jpg)
Some worms are protective; some aren’t: Care is needed!
• Meta-analysis of asthma and association with STH
• STH in general no significant effect
• Ascaris is associated with asthma
• Hookworm is protective
Leonardi-Bee et al Am J Resp Crit Care Med 2006;174:514
![Page 8: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/8.jpg)
Effect of anthelmintics on allergic reactions
• Van den Biggelaar et al J Inf Dis 2004;189:892
Skin reactivity to dust mite antigen increased after STH controlled
![Page 9: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/9.jpg)
• Flohr et al. J Aller Clin Immunol 2006;118:1305
![Page 10: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/10.jpg)
How do parasites exert an effect?
• Brown & Jackson Para Immunol 2004;26:429
Immune response
![Page 11: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/11.jpg)
Trichuris suis for IBD
• Whipworm eggs collected from worms in experimentally infected pigs
• Incubated, made aseptic• 2500 eggs orally every 3 weeks
![Page 12: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/12.jpg)
• All open trials• Significant percent of
remissions for both Crohn’s Disease and Ulcerative Colitis
• No significant side effects
Summers et al. Am J Gastrolenterol 2003;98:2034
Summers et al. Gut 2005;54:87
80% of patients benefited
![Page 13: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/13.jpg)
Necator americanus
![Page 14: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/14.jpg)
Life cycle
• Skin penetration• Blood-lung
migration• Occurs within
48 hrs PI• Juvenile worms
arrive in sm int in 4 weeks PI
• Adults mature at 7-8 weeks PI
![Page 15: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/15.jpg)
N. americanus in gut
• Attaches to mucosa of small intestine
• Sucks blood• Little known about
behaviour of NA in human gut since can not be directly observed
![Page 16: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/16.jpg)
Infective larvae (L3i)
![Page 17: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/17.jpg)
• 25°C• In dark• 7 days
Harada-Mori Technique
![Page 18: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/18.jpg)
![Page 19: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/19.jpg)
![Page 20: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/20.jpg)
12 hr post-infection
![Page 21: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/21.jpg)
1 day post-infection
![Page 22: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/22.jpg)
2 days post-infection
![Page 23: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/23.jpg)
Infection worked!
• We inoculated 9 immunosuppressed Crohn’s disease patients and 3 normal donors with 15 to 101 L3i
• All 9 Crohn’s patients and 2/3 donors developed a patent infection
Insight: Imunosuppressed and normal hosts can be infected with Necator with no
or minimal negative effects.
![Page 24: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/24.jpg)
What did the hosts think?
• Human hosts loved their worms!
Insight: Finding subjects to be inoculated with hookworms is not difficult.
![Page 25: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/25.jpg)
Some problems!
• Penetration site
• Small intestine
![Page 26: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/26.jpg)
2 days post-infection
![Page 27: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/27.jpg)
4 days post-infection
![Page 28: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/28.jpg)
6 days post-infection
![Page 29: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/29.jpg)
7 days post-infection
![Page 30: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/30.jpg)
8 days post-infection
![Page 31: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/31.jpg)
9 days post-infection
![Page 32: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/32.jpg)
10 days post-infection
![Page 33: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/33.jpg)
11 days post-infection
![Page 34: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/34.jpg)
12 days post-infection
![Page 35: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/35.jpg)
15 days post-infection
![Page 36: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/36.jpg)
20 days post-infection
![Page 37: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/37.jpg)
Severe local response on reinfection
Insight: Penetration of L3i is uneventful in most, worrying in some
![Page 38: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/38.jpg)
Why the severe local reaction?
![Page 39: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/39.jpg)
L3i are “dirty”
• L3i are heavily contaminated with faecal bacteria.
• Standard techniques of multiple washing do not reduce the contamination.
• Is the hookworm sheath left on skin or does it remain in epidermis?
• Washing in providone iodine for 15 min was added after harvesting.
• Could L3i be made sterile?
![Page 40: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/40.jpg)
Better Quality L3i
• Melissa Logan – BMedLabSc honours thesis
Bacteria are associated with L3i
![Page 41: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/41.jpg)
In vitro tests
![Page 42: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/42.jpg)
In vivo tests: penetration• 15 L3i; 3 groups – 5 subjects per group
![Page 43: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/43.jpg)
Patency of infection• 100% patency for both techniques
Antibiotic treated L3i were equivalent to standard L3i
![Page 44: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/44.jpg)
Conclusion
• Treatment of L3i with bleach and antibiotics gives viable larvae of comparable potency.
• These L3i are sterile.• Bleach and antibiotic technique should be the
gold standard for L3i for experimental infection.
![Page 45: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/45.jpg)
Recommended Protocol
• Harvest L3i and centrifuge• Place in 0.25% sodium hypochlorite for 10 mins• Wash twice using centrifugation in sterile distilled
water to remove any residual sodium hypochlorite• Place in a solution of benzylepenicillin (180 mg/L) and
ceftazadime (1.0 mg/L) for 60 mins• Centrifuge to remove excess solution• Wash L3i twice using centrifugation in sterile distilled
water to remove any residual antibiotic solution.
Are skin reactions less?
![Page 46: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/46.jpg)
Safety when working with L3i
• For any item in the laboratory a Material Safety Data Sheet (MSDS) is needed.
• MSDS important when L3i of N. americanus are being used in laboratory.
• The MSDS for hookworm said kill spills of L3i with bleach (Health Canada 2001).
• Did this actually work?
![Page 47: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/47.jpg)
What kills L3i rapidly?
• Bleach did not kill L3i• Ethanol 70-100% did• Dettol killed L3i
Insight: Current MSDS was inaccurate! A new one based on
evidence was needed.
![Page 48: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/48.jpg)
New Hookworm MSDS• Speare et al. Australian Journal of Medical Science
2008;29:91-96.
• Online at http://www.tropicalhealthsolutions.com/MSDSNecatoramericanus
![Page 49: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/49.jpg)
Abdominal pain
• Hosts developed central abdominal pain about 3 weeks post-inoculation
![Page 50: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/50.jpg)
Healthy Volunteers:
• 1 of 3: developed vigorous local reaction• 3 of 3: Central, non-colicky abdominal pain
started about 3.5 weeks and persisted for about 5 weeks
1 3 5 7 9
11
13
15
17
19
21
23
25
27
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
0
1
2
3
Abdominal pain - Post Infection with Necator americanus
0 = none; 1 = mild; 2 = moderate; 3 = severe
Day Post-Infection
![Page 51: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/51.jpg)
Reinfection
50
2
50
4
50
6
50
8
51
0
51
2
51
4
51
6
51
8
52
0
52
2
52
4
52
6
52
8
53
0
53
2
53
4
53
6
53
8
54
0
54
2
54
4
54
6
54
8
55
0
55
2
55
4
55
6
55
8
56
0
56
2
56
4
56
6
56
8
57
0
57
2
57
4
57
6
57
8
58
0
0
1
2
3
Abdominal pain - Post Re-Infection with 50 L3i Necator amer-icanus on day 502
0 = none; 1 = mild; 2 = moderate; 3 = severe
Day Post-Infection
![Page 52: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/52.jpg)
What’s happening?
• Allergic reaction develops at the attachment site of the worm.
• Local eosinophilic response.• Each hookworm secretes chemicals to
suppress this reaction.• If this is unsuccessful, the worm lets go and is
carried down the gut.• It attaches to a new site.
![Page 53: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/53.jpg)
Red spots / white spots
![Page 54: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/54.jpg)
Look at the hookworms with capsule endoscopy
• In the past worms in the small intestine could not be studied since they were not accessible to gastroscope or colonoscope
• Now we have capsule endoscopy (CE)• CE was used in this study to count worms,
determine where they were attached, and the host reaction to feeding
![Page 55: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/55.jpg)
The capsule: camera in a pill!
![Page 56: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/56.jpg)
The camera
• Takes 2 images per second
• Transmits these to sensors on abdomen
• Stored on computer• Images read like a
video
![Page 57: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/57.jpg)
Data capture
![Page 58: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/58.jpg)
Data capture
![Page 59: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/59.jpg)
Worms in situ
![Page 60: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/60.jpg)
Male and female
![Page 61: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/61.jpg)
Red spots / white spots
![Page 62: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/62.jpg)
Distribution along small intestine
Yellow bar = NA; Red = red spot; White = white spot
0.00
0.12
0.23
0.35
0.46
0.58
0.69
0.81
0.92
1.04
1.15
HW
0
1
2
3
4
5
6
Transit
RD2: CE #5
![Page 63: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/63.jpg)
Value of capsule endoscopy
• Numbers of hookworm can be counted.• Their relative position along small intestine
can be plotted.• Host response to feeding can be quantified.
Insight: We now have a tool to study hookworms in the small intestine.
![Page 64: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/64.jpg)
What happens when a person is reinfected?
• Two controls reinfected with 50 L3i.• One had originally received 31 L3i and had 6
hookworms in small intestine.• Another had originally received 101 L3i and
had 16 hookworms in small intestine.• Reinfection at 400 and 500 days post-
inoculation.
![Page 65: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/65.jpg)
Rejection started when Necator arrived in small intestine
Croese & Speare. Trends in Parasitology 2006;22(12):547-550.
![Page 66: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/66.jpg)
• Immature worms rejected in small intestine• Each individual host seems to have a “pre-set”
number of worms that will be allowedCroese et al. Gastroenterology 2006;131(2):402-409.
Insight: Repeat infections will be safe unless the host has a high level of
permissiveness.
![Page 67: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/67.jpg)
Can hookworms be used to treat Crohn’s Disease?
• Crohn’s Disease (CD) is an autoimmune disease of the small intestine.
• Severe inflammation, usually segmental.• Typically starts in young adults.• Requires immunosuppressive agents to
control.
![Page 68: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/68.jpg)
Methods
• Single unblinded trial• 9 Crohn’s disease (CD) patients
– 25 L3i of NA for 3; 50 L3i for 5, 100 L3i for 1• 3 healthy volunteers
– 30, 50, 100 L3i • Monitored by Crohn’s Disease Activity Index
(CDAI), Inflammatory Disease Bowel Questionnaire, FBC, clinical biochemistry
• CD patients managed individually by gastroenterologist
![Page 69: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/69.jpg)
Inflammatory Bowel Disease Questionnaire scores
• The IBDQ scores were increased after 20 weeks compared to the scores at the outset (week-20 mean 179, CI 20, vs week-1 mean 151, CI 14: P=0.0544).
0
50
100
150
200
250
Week 1 Week 20
Time from inoculation
IBD
QRemission:IDBQ>170
![Page 70: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/70.jpg)
Crohn’s Disease Activity Index
• The initial CDAI score of each Crohn’s subject vs the scores at week-20 and at week-45 (mean 165, CI 145 vs 64, CI 25, P=0.132; mean 165 vs 75, CI 29; P=0.246).
0
50
100
150
200
250
300
350
400
450
Week 1 Week 20 Week 45
Time from inoculation
CD
AI
Remission:CDAI<150
![Page 71: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/71.jpg)
• The 4-week CDAI mean for the all subjects () at the end of the study was lower compared to lead-in score (week 17-20 mean 87, CI 15 vs week 1-4 mean 141, CI 31; P=0.001);
• This improvement reflected 4 of the 5 subjects with active disease at the outset () achieving a remission (CDAI>150; mean 112, CI 21 vs 211, CI 33; P=0.0001).
0
50
100
150
200
250
300
Week 1-4 Week 5-8 Week 9-12 Week 13-16 Week 17-20
Time from inoculation
CD
AI
Total CDAI>150 CDAI<150
![Page 72: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/72.jpg)
Conclusions
• Crohn’s disease subjects, including those on immunosuppressive drugs, acquired a patent N. americanus infection and appeared to benefit as a result.
• Patients with more severe disease benefited the most.
• Reinoculation did not appear to impact negatively on CD subjects.
• These results justify progression to more sophisticated clinical trials.
![Page 73: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/73.jpg)
Hookworm to treat Crohn’s disease?
Insight: Crohn’s disease patients improved, particularly those with more severe
disease, but additional research is needed to clarify role of hookworms in therapy.
![Page 74: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/74.jpg)
How do hookworms modify host immune responses?
• Brown & Jackson Para Immunol 2004;26:429
Immune response
![Page 75: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/75.jpg)
• Since CD patients were immunosuppressed, we were unable to study effect of N. americanus on immune response.
• Needed people with an autoimmune problem, but not on immunosuppressives.
• Inoculated people with coeliac disease (gluten autoimmunity).
• Test group (received Necator); control group (sham)
Daveson et al. PLoS One 2011;6(3):e17366
![Page 76: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/76.jpg)
Results• All 10 people in test group became infected• Abdominal pain increased wk 3; baseline wk 16• Hookworm group less lethargic
![Page 77: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/77.jpg)
Results (cont)
• Gluten challenge (5 days) – hookworm did not protect.
• Marsh score deteriorated in both groups.• Trend to be less in hookworm group, but not
significant.• Specific markers of systemic immune response
to gluten (EPLISpot) increased significantly after challenge only in control group.
![Page 78: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/78.jpg)
Necator for Treating Coeliac Disease?
Insight: Necator did not protect coeliac disease patients against severe gluten
challenge.However, there was a subjective
impression that Necator “dulled” response to small amounts of gluten.
![Page 79: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/79.jpg)
• Hookworm induced a specific Th2 response
Gaze et al PLoS Pathogens 2012;8(2):e1002520
Systemic immune response
![Page 80: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/80.jpg)
Response in duodenum
• IL-5 increased adjacent to hookworm attachment site
• Plus other changes (read paper – too complex for me!)
Gaze et al PLoS Pathogens 2012;8(2):e1002520
![Page 81: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/81.jpg)
Conclusions
• HW infection induces a systemic, Necator antigen-specific, Th2 response, and a mucosal Th2 response.
• Evidence also of a systemic, but not mucosal HW-specific Th1 response.
• HW dramatically suppressed pro-inflammatory cytokine production (IL-23) in duodenum and upregulated anti-inflammatory and wound healing cytokines (eg, IL-22).
![Page 82: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/82.jpg)
Insights: This is a valuable experimental model for
studying the human immunological response in the gut to hookworm.
Hookworms secrete chemicals with powerful anti-inflammatory effects.
![Page 83: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/83.jpg)
Pharmaceuticals versus Worms?
• Hookworms secrete potent chemicals that have promise for treating human inflammatory diseases.
• Are these best isolated and sold as pills? or• Infect people with hookworms and let the worms
do the immune regulation?• More profit in the former approach, and it may be
more effective and controllable.• Latter approach is simple and cheaper, but
probably less effective.• More evidence needed; so jury is out!
NA
juice
![Page 84: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/84.jpg)
Publications• Croese J, O’Neil J, Masson J, Cooke S, Melrose W, Pritchard D, Speare R. A proof of concept study
establishing Necator americanus in Crohn’s patients and reservoir donors. Gut 2006;55:136-137.• Croese J, Speare R, Wood M, Melrose W. Allergy controls the population density of Necator americanus in
the small intestine. Gastroenterology 2006;131(2):402-409.• Croese J, Speare R. Intestinal allergy expels hookworms: seeing is believing. Trends in Parasitology
2006;22(12):547-550.• Daveson AJ, Jones DM, Gaze S, McSorley H, Clouston A, Pascoe A, Cooke S, Speare R, Macdonald GA,
Anderson R, McCarthy JS, Loukas A, Croese J. Effect of hookworm infection on wheat challenge in celiac disease - a randomised double-blinded placebo controlled trial. PLoS One 2011;6(3):e17366.
• Gaze S, McSorley HJ, Daveson J, Jones D, Bethony JM, Oliviera LM, Speare R, Mccarthy JS, Engwerda CR, Croese J, Loukas A. Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS pathogens 2012;8(2):e1002520.
• Logan M. Methods in improving the quality of Nector americanus larvae for use in therapeutic applications. BMedLabSc honours thesis, James Cook University. 2009.
• McSorley HJ, Gaze S, Daveson J, Jones D, Anderson RP, Clouston A, Ruyssers NE, Speare R, McCarthy JS, Engwerda CR, Croese J, Loukas A. Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS One 2011;6(9):e24092.
• Speare R, Melrose W, Cooke S, Croese J. Techniques to kill infective larvae of human hookworm, Necator americanus, in the laboratory and a new Material Safety Data Sheet. Australian Journal of Medical Science 2008;29:91-96.
![Page 85: Insights from experimentally infecting humans with hookworm](https://reader037.vdocuments.us/reader037/viewer/2022103101/56814354550346895dafd157/html5/thumbnails/85.jpg)
Source of Images(if not original)
• N. americanus en face view: http://www.columbia.edu/itc/hs/medical/pathophys/parasitology/2004/lecture02Slides_files/slide0005.html
• Hookworm life cycle: CDC Diagnostic Parasitology web site• Trichuris and hookworm eggs: CDC Diagnostic Parasitology web site